Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2015, Article ID 731284, 3 pages
http://dx.doi.org/10.1155/2015/731284
Case Report

Sildenafil Induced Acute Interstitial Nephritis

1William Beaumont Army Medical Center, 5005 N. Piedras Street, El Paso, TX 79920, USA
2ProPath Services, LLP, 1355 River Bend Drive, Dallas, TX 75247, USA

Received 17 June 2015; Accepted 24 August 2015

Academic Editor: Ichiei Narita

Copyright © 2015 Ryan Burkhart et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Praga and E. González, “Acute interstitial nephritis,” Kidney International, vol. 77, no. 11, pp. 956–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. K. Muriithi, N. Leung, A. M. Valeri et al., “Biopsy-proven acute interstitial nephritis, 1993-2011: a case series,” American Journal of Kidney Diseases, vol. 64, no. 4, pp. 558–566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. V. Warren, S. M. Korbet, M. M. Schwartz, and E. J. Lewis, “Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs,” American Journal of Kidney Diseases, vol. 13, no. 2, pp. 127–130, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Champion de Crespigny, G. J. Becker, B. U. Ihle, N. M. A. Walter, C. A. Wright, and P. Kincaid-Smith, “Renal failure and nephrotic syndrome associated with sulindac,” Clinical Nephrology, vol. 30, no. 1, pp. 52–55, 1988. View at Google Scholar · View at Scopus
  5. E. G. Neilson, “Pathogenesis and therapy of interstitial nephritis,” Kidney International, vol. 35, no. 5, pp. 1257–1270, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Ten, V. E. Torres, D. S. Milliner, T. R. Schwab, K. E. Holley, and G. J. Gleich, “Acute interstitial nephritis: immunologic and clinical aspects,” Mayo Clinic Proceedings, vol. 63, no. 9, pp. 921–930, 1988. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Rossert, “Drug-induced acute interstitial nephritis,” Kidney International, vol. 60, no. 2, pp. 804–817, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Porile, G. L. Bakris, and S. Garrella, “Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steriod therapy,” Journal of Clinical Pharmacology, vol. 30, no. 5, pp. 468–475, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Schwarz, P. H. Krause, U. Kunzendorf, F. Keller, and A. Distler, “The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis,” Clinical Nephrology, vol. 54, no. 3, pp. 179–190, 2000. View at Google Scholar · View at Scopus
  10. E. G. Neilson, “Mechanisms of disease: fibroblasts—a new look at an old problem,” Nature Clinical Practice Nephrology, vol. 2, no. 2, pp. 101–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Cameron, “The nephrotic syndrome and its complications,” American Journal of Kidney Diseases, vol. 10, no. 3, pp. 157–171, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Feehally, N. P. Kendell, P. G. F. Swift, and J. Walls, “High incidence of minimal change nephrotic syndrome in Asians,” Archives of Disease in Childhood, vol. 60, no. 11, pp. 1018–1020, 1985. View at Publisher · View at Google Scholar · View at Scopus